SCIENCE FLOW LAB A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.9% 2.9% 2.8% 1.2% 8.7%  
Credit score (0-100)  70 58 57 81 27  
Credit rating  A BBB BBB A BB  
Credit limit (kDKK)  0.1 -0.0 0.0 56.6 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  6,412 4,083 4,454 6,103 7,187  
EBITDA  4,282 4,081 4,454 6,103 7,187  
EBIT  369 169 541 2,191 3,275  
Pre-tax profit (PTP)  53.0 -43.0 385.2 2,105.7 3,275.2  
Net earnings  41.4 -33.5 300.4 1,641.8 2,554.7  
Pre-tax profit without non-rec. items  53.0 -43.0 385 2,106 3,275  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -1,126 -1,160 -860 782 3,337  
Interest-bearing liabilities  18,724 10,634 7,205 2,677 52.5  
Balance sheet total (assets)  22,399 12,928 9,033 5,666 4,993  

Net Debt  18,724 10,634 7,205 2,677 52.5  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  6,412 4,083 4,454 6,103 7,187  
Gross profit growth  272.5% -36.3% 9.1% 37.0% 17.7%  
Employees  2 0 0 0 0  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  22,399 12,928 9,033 5,666 4,993  
Balance sheet change%  10.4% -42.3% -30.1% -37.3% -11.9%  
Added value  4,281.6 4,080.8 4,453.7 6,103.5 7,186.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -7,824 -7,824 -7,824 -7,824 -7,824  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.8% 4.1% 12.2% 35.9% 45.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  1.6% 0.9% 4.5% 28.2% 61.5%  
ROI %  1.7% 1.0% 4.9% 33.1% 85.0%  
ROE %  0.2% -0.2% 2.7% 33.5% 124.0%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  -4.8% -8.2% -8.7% 13.8% 66.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  437.3% 260.6% 161.8% 43.9% 0.7%  
Gearing %  -1,662.2% -916.8% -838.3% 342.2% 1.6%  
Net interest  0 0 0 0 0  
Financing costs %  1.8% 1.4% 1.8% 1.7% 0.0%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.3 0.1 0.1 0.4 3.0  
Current Ratio  0.3 0.1 0.1 0.4 3.0  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -13,333.3 -10,315.2 -6,963.2 -2,269.2 3,337.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  2,141 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  2,141 0 0 0 0  
EBIT / employee  185 0 0 0 0  
Net earnings / employee  21 0 0 0 0